DCAL167.18

Dishman Carbogen Amcis Limited

· Pharma & Health
₹ CrorePeersHIKALSOLARAPANACEABIOINDSWFTLABSAIPARENTINDOCOSMSPHARMAWINDLASMcap ₹2,621 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment2,459.12,683.92,941.92,941.9
+ Capital Work-in-Progress500.8251.7275.0275.0
+ Investment Property4.34.14.64.6
+ Goodwill3,910.74,053.64,798.44,798.4
+ Other Intangibles78.277.8104.4104.4
+ Intangibles under Development144.9215.2295.3295.3
+ Non-current Investments78.972.075.375.3
+ Long-term Loans47.51.71.91.9
+ Other Non-current Financial Assets22.026.3149.4149.4
Non-current Financial Assets148.399.9226.6226.6
+ Deferred Tax Assets10.812.883.483.4
+ Other Non-current Assets396.1399.8351.7351.7
Total Non-current Assets7,653.27,798.79,081.29,081.2
Current Assets
+ Inventories882.9900.21,019.11,019.1
+ Current Investments23.325.416.216.2
+ Trade Receivables461.1665.1672.9672.9
+ Cash & Cash Equivalents264.1341.1787.8787.8
+ Other Bank Balances149.3166.0203.5203.5
+ Short-term Loans3.43.63.33.3
+ Other Current Financial Assets13.415.323.423.4
Current Financial Assets914.61,216.61,707.01,707.0
+ Other Current Assets130.783.6116.0116.0
Total Current Assets1,928.22,200.42,842.12,842.1
Total Assets9,581.49,999.211,923.311,923.3
Equity
+ Equity Share Capital31.431.431.431.4
+ Other Equity / Reserves5,596.15,800.26,645.56,645.5
Equity — Owners of Parent5,627.55,831.56,676.96,676.9
Total Equity5,627.55,831.56,676.96,676.9
Liabilities
+ Borrowings — Non-current245.61,149.21,534.91,534.9
+ Other Non-current Financial Liab286.615.5252.1252.1
Non-current Financial Liabilities532.21,164.71,787.01,787.0
+ Provisions — Non-current379.0352.4427.9427.9
+ Deferred Tax Liabilities39.312.311.911.9
+ Other Non-current Liabilities448.6686.7702.6702.6
Non-current Liabilities1,399.22,242.82,929.42,929.4
+ Borrowings — Current1,718.8934.71,240.51,240.5
+ Trade Payables244.1230.7211.2211.2
+ Other Current Financial Liab244.6211.4426.4426.4
Current Financial Liabilities2,207.51,376.81,878.11,878.1
+ Provisions — Current31.53.814.314.3
+ Current Tax Liabilities19.341.888.888.8
+ Other Current Liabilities296.4502.5335.8335.8
Current Liabilities2,554.71,924.82,317.12,317.1
Total Liabilities3,953.94,167.65,246.45,246.4
Total Equity & Liabilities9,581.49,999.211,923.311,923.3
Liabilities — additional as-filed lines
+ Deferred Government Grants — Non-current26.80.00.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current7.07.07.0
+ Dues to Other Creditors — Current223.7204.2204.2
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.